The University of Utah Health Immunology, Inflammation and Infectious Disease Initiative (3i), in conjunction with the University of Utah Molecular Medicine program (U2M2), has awarded program planning grants to four collaborative research projects.... Read More
Studying Cytomegalovirus & Congenital Hearing Loss in Infants
“Blindness separates people from things; deafness separates people from people.”—Helen Keller
Our research team is a unique, truly translational bench to bedside program dedicated to treat cytomegalovirus (CMV).
The clinical branch is focused on the role of valganciclovir for congenitally infected (cCMV) infants with isolated sensorineural hearing loss. We are conducting an NIH funded multi-institutional clinical trial to address this question (ValEAR CMV trial). Our laboratory is particularly interested in understanding the mechanisms underlying CMV induced hearing loss.
News & Blog
University of Utah Health researchers found that at least two common techniques used in ear, nose, and throat surgeries can generate airborne particles containing evidence of viral DNA that are small enough to penetrate surgical masks. ... Read MoreSurgery
CMV is actually a version of the herpes virus, similar to the common chicken pox disease found around the world. ... Read MoreSurgery
A University of Utah-led nationwide clinical trial will test a novel approach to combat hearing loss in children infected by a relatively unknown virus, cytomegalovirus (CMV). ... Read MoreSurgery,Pediatrics